EFFICACY OF PRANAYAMIC BREATHING ON COGNITION AND INSTRUMENTAL ACTIVITIES OF DAILY LIVING IN TYPE2 DIABETES MELLITUS.

2021 ◽  
pp. 36-39
Author(s):  
Manju Unnikrishnan ◽  
Titto Cherian

Type 2 diabetes is inherent in poor physical performance and cognitive functions that affect patients' overall performance in their activities of daily living (ADL) (Lindsay et al., 2016) . Diabetes and cognitive dysfunction are linked, according to epidemiological evidence. When compared to adults without type 2 diabetes, adults who develop type 2 diabetes later in life have cognitive decits; psychomotor productivity, executive function, and learning and memory skills are often the most affected(Wrighten et al., 2009; Okereke, 2008.).So this study aims to investigate the. efcacy of pranayamic breathing on cognition and Instrumental Activities of Daily living (IADL) in type2 diabetes mellitus.(DM). Thirty type2 Diabetic patients between 45-65 years of age were selected randomly and were divided into two groups. Group A received pranayama breathing with conventional physiotherapy for 5 days a week for 4 weeks. Group B received conventional physiotherapy. Montreal cognitive assessment scale (MoCA) and Functional activities questionnaire (FAQ) were reported to determine cognition and IADL.Between group comparison of MOCAshowed that the paired difference obtained from pretest to post test in the experimental group was 3.80±0.862 and in the conventional group 1.13±0.352, the effect size was 4.05 and this observed difference was statistically signicant (p<0.001). Between group comparison of FAQ says that the paired difference obtained was 3.33±0.816 for experimental group and 1.80±1.47 for control group. The effect size observed was 1.28 and it was statistically signicant (p=0.002).The ndings of the study show that there is signicant difference between the scores of two groups which concludes , pranayama breathing with conventional physiotherapy has shown signicant improvement in cognition and Instrumental Activities of daily living among Type 2 Diabetes Mellitus..

2019 ◽  
Vol 21 (4) ◽  
pp. 445-453 ◽  
Author(s):  
Mi Mi Thet Mon Win ◽  
Kiyoko Fukai ◽  
Htwe Htwe Nyunt ◽  
Yoshimi Hyodo ◽  
Khaing Zaw Linn

Author(s):  
Deepasha Shahi Bagzai ◽  
Darshna Jain ◽  
Anurag Kesarwani

Background: Thyroid disorders and diabetes mellitus are two common endocrine disorders that are commonly encountered in clinical practice.  The relationship between thyroid disease and diabetes is important for physicians to understand in order to provide the best treatment for both conditions. The aim of this study was to assess thyroid function in Type2 Diabetes Mellitus patients of malwa region and raise awareness about thyroid dysfunction in newly diagnosed T2DM patients. Methods: In this case control study, a total of 200 subjects were chosen. Group I consisted of 100 diagnosed type 2 diabetes cases and Group II 100 sex matched stable controls. After receiving informed consent, patients were enrolled. Thyroid dysfunction in Type2 diabetes mellitus was assessed using biochemical parameters such as fasting plasma glucose, total triiodothyronine T3, total thyroxine T4, and thyroid stimulating hormone (TSH). Results: When diabetic patients were compared to healthy controls, their fasting blood glucose and serum TSH levels were substantially higher. In these two classes, however, there was no substantial difference in serum T3 and T4 levels. The findings suggest that diabetic patients have subclinical hypothyroidism as opposed to the control group in the study population Conclusion: From this current study it has been observed that thyroid function levels were altered in Diabetes mellitus patients, especially TSH levels. so it is suggested that diabetes mellitus patients should be screened for thyroid function studies on a regular basis to prevent further complications of thyroid dysfuction. Keywords: Type 2 diabetes mellitus, Thyroid dysfunction.


Medicina ◽  
2020 ◽  
Vol 56 (4) ◽  
pp. 164
Author(s):  
Wojciech Matuszewski ◽  
Angelika Baranowska-Jurkun ◽  
Magdalena M. Stefanowicz-Rutkowska ◽  
Robert Modzelewski ◽  
Janusz Pieczyński ◽  
...  

Background and Objectives: The global epidemic of diabetes, especially type 2 (DM2), is related to lifestyle changes, obesity, and the process of population aging. Diabetic retinopathy (DR) is the most serious complication of the eye caused by diabetes. The aim of this research was to assess the prevalence of diabetic retinopathy in type 1 and type 2 diabetes mellitus patients in north-east Poland. Materials and Methods: The eye fundus was assessed on the basis of two-field 50 degrees color fundus photographs that showed the optic nerve and macula in the center after the pupil was dilated with 1% tropicamide. Results: The experimental group included 315 (26%) patients with type 1 diabetes mellitus (DM1) and 894 (74%) patients with DM2. DM1 patients were diagnosed with DR in 32.58% of cases, with non-proliferative diabetic retinopathy (NPDR) in 24.44% of cases, proliferative diabetic retinopathy (PDR) in 1.59% of cases, diabetic macular edema (DME) in 5.40% of cases, and PDR with DME in 0.95% of cases. DR was found in DM2 patients in 23.04% of cases, NPDR in 17.11% of cases, PDR in 1.01% of cases, DME in 4.81% of cases, and PDR with DME in 0.11% of cases. Conclusions: The presented study is the first Polish study on the prevalence of diabetic retinopathy presenting a large group of patients, and its results could be extrapolated to the whole country. Diabetic retinopathy was found in 25.48% of patients in the whole experimental group. The above results place Poland within the European average, indicating the quality of diabetic care offered in Poland, based on the number of observed complications.


2014 ◽  
Vol 11 (4) ◽  
pp. 25-31 ◽  
Author(s):  
Nina Aleksandrovna Petunina ◽  
Anna Leont'evna Terekhova

This review presents data on the efficacy and safety of alogliptin, a new representative of the DPP-4 inhibitors, in adult patients with type2 diabetes mellitus (DM type 2) as monotherapy or in combination with metformin, pioglitazone, glibenclamide and insulin.


2020 ◽  
Vol 8 (9) ◽  
pp. 1196-1200
Author(s):  
Mayur Mewada ◽  

The glycemic index or G.I is a measure of the effects of carbohydrates on blood sugar levels. The individuals who followed a low-GI diet over many years are at a significantly lower risk for developing both type 2 diabetes and coronary heart disease than others. Therefore, attempt is made to study the complications prevalent in patients with long-standing diabetes and their co-relation with the glycemic index. Objectives: To calculate the glycemic index (G.I) of the diet (MeanG.I considering dietary chart of one week) of patients with Type2 Diabetes of more than 10 years duration.To study the complications prevalent at the time of inclusion in the study, in these patients with type 2 diabetes of chronic duration.To co-relate the G.I (Glycemic Index) of the diet with the prevalence of complications in patients with type 2 diabetes. Methodology: Patients attending diabetic OPD as well as indoor patients were included . All patients with a history of type 2 diabetes mellitus of more than ten year duration with documented reports for the same were included.Duration of study : 1 yearGlycemic index of the mixed meal consumed by the patient based on this weekly dietary chart was calculated.Study subjects : 102 Data analysis done by SPSS.Ethical clearance was taken. Results and Conclusions: All microvascular or macrovascular complications had a direct co-relation with glycemic index.The maximum glycemic index observed was 124.16 and the minimum was 36.73. The mean glycemic index seen was 72.06.


Sign in / Sign up

Export Citation Format

Share Document